Skip to content

Clinical trials

Phase 1/2 Digestive System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Neoplasms Phase: Phase 1/2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20112
20121
20172
20182
20201
20211
20221
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Isofol Medical AB3
DualityBio Inc.1
Erasca, Inc.1
Hoffmann-La Roche1
Kyowa Kirin Co., Ltd.1
Novartis Pharmaceuticals1
Pengyuan Liu1
Sichuan Baili Pharmaceutical Co., Ltd.1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Theseus Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Neoplasms15
Gastrointestinal Neoplasms9
Colorectal Neoplasms8
Gastrointestinal Diseases7
Neoplasms7
Digestive System Diseases6
Intestinal Neoplasms6
Intestinal Diseases5
Neoplasms by Site5
Colonic Diseases4

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.